Key result
Treatment with high-dose corticosteroids dramatically resolved refractory heart failure and improved left ventricular ejection fraction from 30% to 55% in a 27-year-old woman with lupus myocarditis.
Case Report (n=1)
No
High-dose corticosteroid and immunosuppressive therapy can dramatically improve severe, refractory heart failure caused by acute lupus myocarditis.
Answers are grounded in this paper and cite their sources.
Supports high-dose corticosteroids in refractory lupus myocarditis HF; single-case evidence leaves open need for prospective trials.
A young woman who had a delivery history 3 months previously presented with dyspnea and orthopnea. Initial findings of physical examination, chest radiography, and echocardiogram showed typical congestive heart failure with severe left ventricular (LV) dysfunction. At first, we considered peripartum cardiomyopathy because she had given birth to a baby 3 months previously. However, even though we massively tried conventional drug therapy for 10 days, the patient still remained with refractory heart failure. We performed additional laboratory studies such as complement level and autoantibodies, of which the results supported systemic lupus erythematosus. We could make the diagnosis of acute lupus myocarditis and treated her with corticosteroid. The symptoms were dramatically disappeared and LV function also improved.
No takes yet. Share an insight, caveat, or question.
Woo et al. (2009) conducted a case report in Lupus Myocarditis (n=1). Corticosteroids (methylprednisolone and prednisolone) was evaluated on Improvement in heart failure symptoms and left ventricular ejection fraction. Treatment with high-dose corticosteroids dramatically resolved refractory heart failure and improved left ventricular ejection fraction from 30% to 55% in a 27-year-old woman with lupus myocarditis.
Synapse has enriched 10 related papers. Consider them for comparative context: